In our in vivo models, we show stereotactic injection of IGF2 not only improves rotarod behavior and decreases mHTT aggregates, but also slightly increases level of p-AKT/AKT ratio in R6/2 HD transgenic mice (Fig. 5). This evidence concerns the gene AKT1 and Huntington disease.